1
TÍTULO: Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
AUTORES: Burtness, B; Haddad, R; Dinis, J; Trigo, J; Yokota, T; De Souza Viana, L; Romanov, I; Vermorken, J; Bourhis, J; Tahara, M; Martins Segalla, JG; Psyrri, A; Vasilevskaya, I; Nangia, CS; Chaves Conde, M; Kiyota, N; Homma, A; Holeckova, P; Del Campo, JM; Asarawala, N; Nicolau, UR; Rauch, D; Even, C; Wang, B; Gibson, N; Ehrnrooth, E; Harrington, K; Cohen, EEW; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA ONCOLOGY, VOLUME: 5, NÚMERO: 8
INDEXADO EM: Scopus WOS
2
TÍTULO: Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts  Full Text
AUTORES: Gilberto de Castro; Gustavo V Alves; Ana F Castro; Aline L F Chaves; Pedro De Marchi; Thiago B de Oliveira; Fernando L Dias; Rodrigo S C Guindalini; Ulisses R Nicolau; Andrey Soares; Paulo A R Mora;
PUBLICAÇÃO: 2018, FONTE: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, VOLUME: 131
INDEXADO EM: Scopus WOS